PAD is a progressive cardiovascular disease resulting from narrowing or obstruction of the arteries in the lower limbs, a consequence of atherosclerosis — a chronic process characterized by the formation of fatty plaques and fibrous tissue in the arterial wall, leading to reduced blood flow. Its development is favoured by risk factors such as smoking, high blood pressure, diabetes, and high cholesterol. Although often asymptomatic in the early stages, it typically manifests as intermittent claudication, defined by pain or cramps that occur on walking and improve with rest. However, the more one walks, the less pain tends to occur over time, since regular exercise improves muscle oxygenation and helps to stop the disease progression. In contrast, the absence of consistent physical activity leads to progressive reduction of mobility and autonomy, leading to a sedentary lifestyle, functional dependence, social isolation, and a high prevalence of symptoms of anxiety and depression.

Home / Publications / Publication

Home / Publications / Publication

Pessoa a caminhar

Publication type: Article Summary
Original title: Effect of a monitored home-based exercise program combined with a behavior change intervention and a smartphone app on walking distances and quality of life in adults with peripheral arterial disease: the WalkingPad randomized clinical trial
Article publication date: November 2023
Source: Frontiers in Cardiovascular Medicine
Authors: Ivone Silva, Célia Sofia Moreira, Susana Pedras, Rafaela Oliveira, Carlos Veiga, Luís Moreira, Daniel Santarém, Daniel Guedes & Hugo Paredes

What is the goal, target audience, and areas of digital health it addresses?
     The WalkingPad study aimed to evaluate the effectiveness of a home-based exercise therapy program combined with a behavioural change intervention, supported by a mobile application developed for remote monitoring and follow-up of people with peripheral arterial disease (PAD) and intermittent claudication. The study is intended for healthcare professionals, researchers in cardiovascular rehabilitation and health technologies, as well as decision-makers and managers interested in digital rehabilitation solutions, falling within the areas of e-Health, m-Health, digital therapeutics, telemonitoring, and digital vascular rehabilitation.

What is the context?
     PAD is a progressive cardiovascular disease resulting from narrowing or obstruction of the arteries in the lower limbs, a consequence of atherosclerosis — a chronic process characterized by the formation of fatty plaques and fibrous tissue in the arterial wall, leading to reduced blood flow. Its development is favoured by risk factors such as smoking, high blood pressure, diabetes, and high cholesterol. Although often asymptomatic in the early stages, it typically manifests as intermittent claudication, defined by pain or cramps that occur on walking and improve with rest. However, the more one walks, the less pain tends to occur over time, since regular exercise improves muscle oxygenation and helps to stop the disease progression. In contrast, the absence of consistent physical activity leads to progressive reduction of mobility and autonomy, leading to a sedentary lifestyle, functional dependence, social isolation, and a high prevalence of symptoms of anxiety and depression.

     In addition to its local impact on the lower limbs, PAD is a systemic marker of atherosclerosis and is associated with an increased risk of acute myocardial infarction, stroke, and early mortality. It should therefore be understood as a public health problem with a strong impact on quality of life and overall cardiovascular prognosis.

What are the current approaches?
     International recommendations point to supervised exercise programs in a clinical setting as the first-line treatment for PAD, with widely proven benefits in improving walking distance and quality of life. However, the scarcity of specialized centres, the associated costs, and logistical barriers hinder their widespread implementation and reduce accessibility for patients. As an alternative, home-based exercise therapy is a viable option, allowing structured walking to be carried out in a residential setting. Although effective in the short term, the lack of direct supervision compromises patient motivation and limits the sustainability of results over time.

     In this scenario, behavioural change interventions aimed at reinforcing motivation and promoting adherence to exercise, often associated with healthy lifestyle counselling strategies, have gained relevance. At the same time, the development of digital tools such as mobile applications, pedometers, accelerometers, and other portable devices, has facilitated the monitoring of physical activity, delivery of personalized reminders, and sharing data with health professionals. Despite their potential, these digital solutions continue to face significant limitations, including limited clinical validation, poor integration into healthcare systems, and usability difficulties in older populations, factors that limit their effectiveness and hinder large-scale adoption.

What does innovation consist of? How is the impact of this study assessed?
     The innovation of WalkingPad lay in the development of a mobile application and web platform designed specifically to support home-based exercise programs for people with PAD and intermittent claudication. WalkingPad aims to improve pain-free walking distance, quality of life, and prevent severe complications such as amputations.

     This technological solution enabled the remote prescription and monitoring of individualized walking plans — with routes close to the patient’s home and intensity tailored to their clinical condition — as well as the automatic recording of distance travelled, real-time self-recording of pain, delivery of motivational messages and personalized progression recommendations (such as taking breaks when claudication pain increases and recording that moment). In addition, it integrated geolocation systems and biometric parameters that validated the patient’s identity and clinical condition, analyzing gait patterns and detecting changes that could signal disease progression or indicate that the walk had been performed by another person. The data was securely transmitted to the web platform, allowing professionals to track clinical progress and provide personalized feedback.

     The program also incorporated a behavioural intervention based on Self-Determination Theory, including two 120-minute face-to-face sessions and regular telephone calls over 24 weeks, conducted by a psychologist, with the aim of supporting self-management, identifying individual barriers, and reinforcing progress. Additional telephone calls were made in cases of program interruption to encourage continuation.

     The clinical trial took place at the Centro Hospitalar Universitário de Santo António, involving 73 participants with PAD and intermittent claudication, of whom 60 completed the three assessments (baseline, 3 and 6 months). Patients were randomly assigned to two groups: the experimental group (n=38), which used the WalkingPad, and the control group (n=35), which manually recorded sessions in a paper diary. Both groups received standard treatment and a structured exercise prescription (30 minutes, three times a week, to near-maximum pain).

     The impact of the intervention was assessed using primary outcomes — Pain-Free Walking Distance, Functional Walking Distance, Maximal Walking Distance, and 6-Minute Walk Distance — and secondary outcomes, including quality of life (Vascular Disease-Specific Quality of Life Questionnaire and 12-Item Short Form Health Survey), functional performance (Walking Impairment Questionnaire), and emotional state (Geriatric Anxiety Inventory-Short Form and Geriatric Depression Scale-5).

What are the main results? What is the future of this approach?
     The results of this study demonstrated significant clinical improvements in the group that used the mobile application in addition to structured exercise prescription and behavioural intervention. At 3 months, there was an average increase of 93 metres in Pain-Free Walking Distance and 136 metres in Functional Walking Distance, reflecting significant gains in exercise tolerance. At 6 months, progress was even more consistent, with average increases of 210 metres in Maximal Walking Distance and 48 metres in 6-Minute Walk Distance. In addition to these functional parameters, significant improvements were noted in quality of life, in the perception of walking ability and in emotional state, with a reduction in symptoms of anxiety and depression.

     The control group, which followed the same exercise program but only used manual recording in a paper diary, also showed positive progress, albeit to a lesser extent. At 3 months, the average increase was 42 metres in Pain-Free Walking Distance and 61 metres in Functional Walking Distance, while at 6 months, 108 metres were observed in Maximal Walking Distance and 19 metres in 6-Minute Walk Distance. These results, although encouraging, showed a substantially lower impact compared to the digitally monitored group, confirming that the integration of the application reinforced adherence, consistency, and effectiveness of rehabilitation.

     The future of this approach lies in its large-scale integration into healthcare systems and its adaptation to other chronic cardiovascular conditions, paving the way for more personalized, accessible, and sustainable rehabilitation models capable of amplifying the clinical and social impact of vascular rehabilitation.

Do you have an innovative idea in healthcare field?

Share it with us and see it come to life.
We will help bring your projects to life!

Newsletter

Receive the latest updates from the InovarSaúde portal.

República Portuguesa logo
logotipo SNS
SPMS logotipo

Follow Us

YouTube
LinkedIn

Co-funded by

PRR Logotipo
república Portuguesa logo
União Europeia Logo

Newsletter

Receive the latest updates from the InovarSaúde portal.

República Portuguesa logo
SNS Logo
SPMS Logo

Follow Us

Co-funded by

PRR Logotipo
República Portuguesa logo
União Europeia Logo

Home / Publications / Publication

Pessoa a caminhar

Publication type: Article Summary
Original title: Effect of a monitored home-based exercise program combined with a behavior change intervention and a smartphone app on walking distances and quality of life in adults with peripheral arterial disease: the WalkingPad randomized clinical trial
Article publication date: November 2023
Source: Frontiers in Cardiovascular Medicine
Authors: Ivone Silva, Célia Sofia Moreira, Susana Pedras, Rafaela Oliveira, Carlos Veiga, Luís Moreira, Daniel Santarém, Daniel Guedes & Hugo Paredes

What is the goal, target audience, and areas of digital health it addresses?
     The WalkingPad study aimed to evaluate the effectiveness of a home-based exercise therapy program combined with a behavioural change intervention, supported by a mobile application developed for remote monitoring and follow-up of people with peripheral arterial disease (PAD) and intermittent claudication. The study is intended for healthcare professionals, researchers in cardiovascular rehabilitation and health technologies, as well as decision-makers and managers interested in digital rehabilitation solutions, falling within the areas of e-Health, m-Health, digital therapeutics, telemonitoring, and digital vascular rehabilitation.

What is the context?
     PAD is a progressive cardiovascular disease resulting from narrowing or obstruction of the arteries in the lower limbs, a consequence of atherosclerosis — a chronic process characterized by the formation of fatty plaques and fibrous tissue in the arterial wall, leading to reduced blood flow. Its development is favoured by risk factors such as smoking, high blood pressure, diabetes, and high cholesterol. Although often asymptomatic in the early stages, it typically manifests as intermittent claudication, defined by pain or cramps that occur on walking and improve with rest. However, the more one walks, the less pain tends to occur over time, since regular exercise improves muscle oxygenation and helps to stop the disease progression. In contrast, the absence of consistent physical activity leads to progressive reduction of mobility and autonomy, leading to a sedentary lifestyle, functional dependence, social isolation, and a high prevalence of symptoms of anxiety and depression.

     In addition to its local impact on the lower limbs, PAD is a systemic marker of atherosclerosis and is associated with an increased risk of acute myocardial infarction, stroke, and early mortality. It should therefore be understood as a public health problem with a strong impact on quality of life and overall cardiovascular prognosis.

What are the current approaches?
     International recommendations point to supervised exercise programs in a clinical setting as the first-line treatment for PAD, with widely proven benefits in improving walking distance and quality of life. However, the scarcity of specialized centres, the associated costs, and logistical barriers hinder their widespread implementation and reduce accessibility for patients. As an alternative, home-based exercise therapy is a viable option, allowing structured walking to be carried out in a residential setting. Although effective in the short term, the lack of direct supervision compromises patient motivation and limits the sustainability of results over time.

     In this scenario, behavioural change interventions aimed at reinforcing motivation and promoting adherence to exercise, often associated with healthy lifestyle counselling strategies, have gained relevance. At the same time, the development of digital tools such as mobile applications, pedometers, accelerometers, and other portable devices, has facilitated the monitoring of physical activity, delivery of personalized reminders, and sharing data with health professionals. Despite their potential, these digital solutions continue to face significant limitations, including limited clinical validation, poor integration into healthcare systems, and usability difficulties in older populations, factors that limit their effectiveness and hinder large-scale adoption.

What does innovation consist of? How is the impact of this study assessed?
     The innovation of WalkingPad lay in the development of a mobile application and web platform designed specifically to support home-based exercise programs for people with PAD and intermittent claudication. WalkingPad aims to improve pain-free walking distance, quality of life, and prevent severe complications such as amputations.

     This technological solution enabled the remote prescription and monitoring of individualized walking plans — with routes close to the patient’s home and intensity tailored to their clinical condition — as well as the automatic recording of distance travelled, real-time self-recording of pain, delivery of motivational messages and personalized progression recommendations (such as taking breaks when claudication pain increases and recording that moment). In addition, it integrated geolocation systems and biometric parameters that validated the patient’s identity and clinical condition, analyzing gait patterns and detecting changes that could signal disease progression or indicate that the walk had been performed by another person. The data was securely transmitted to the web platform, allowing professionals to track clinical progress and provide personalized feedback.

     The program also incorporated a behavioural intervention based on Self-Determination Theory, including two 120-minute face-to-face sessions and regular telephone calls over 24 weeks, conducted by a psychologist, with the aim of supporting self-management, identifying individual barriers, and reinforcing progress. Additional telephone calls were made in cases of program interruption to encourage continuation.

     The clinical trial took place at the Centro Hospitalar Universitário de Santo António, involving 73 participants with PAD and intermittent claudication, of whom 60 completed the three assessments (baseline, 3 and 6 months). Patients were randomly assigned to two groups: the experimental group (n=38), which used the WalkingPad, and the control group (n=35), which manually recorded sessions in a paper diary. Both groups received standard treatment and a structured exercise prescription (30 minutes, three times a week, to near-maximum pain).

     The impact of the intervention was assessed using primary outcomes — Pain-Free Walking Distance, Functional Walking Distance, Maximal Walking Distance, and 6-Minute Walk Distance — and secondary outcomes, including quality of life (Vascular Disease-Specific Quality of Life Questionnaire and 12-Item Short Form Health Survey), functional performance (Walking Impairment Questionnaire), and emotional state (Geriatric Anxiety Inventory-Short Form and Geriatric Depression Scale-5).

What are the main results? What is the future of this approach?
     The results of this study demonstrated significant clinical improvements in the group that used the mobile application in addition to structured exercise prescription and behavioural intervention. At 3 months, there was an average increase of 93 metres in Pain-Free Walking Distance and 136 metres in Functional Walking Distance, reflecting significant gains in exercise tolerance. At 6 months, progress was even more consistent, with average increases of 210 metres in Maximal Walking Distance and 48 metres in 6-Minute Walk Distance. In addition to these functional parameters, significant improvements were noted in quality of life, in the perception of walking ability and in emotional state, with a reduction in symptoms of anxiety and depression.

     The control group, which followed the same exercise program but only used manual recording in a paper diary, also showed positive progress, albeit to a lesser extent. At 3 months, the average increase was 42 metres in Pain-Free Walking Distance and 61 metres in Functional Walking Distance, while at 6 months, 108 metres were observed in Maximal Walking Distance and 19 metres in 6-Minute Walk Distance. These results, although encouraging, showed a substantially lower impact compared to the digitally monitored group, confirming that the integration of the application reinforced adherence, consistency, and effectiveness of rehabilitation.

     The future of this approach lies in its large-scale integration into healthcare systems and its adaptation to other chronic cardiovascular conditions, paving the way for more personalized, accessible, and sustainable rehabilitation models capable of amplifying the clinical and social impact of vascular rehabilitation.

Cadeira de rodas

Autonomous Patient Mobility in a Hospital Environment

The internal transport of patients in healthcare institutions, although at first glance it may seem like a simple task, represents a complex, continuous, demanding and time-consuming logistical operation that cuts across all levels of the…

Read more
Voz em IA

The Future of Diagnostics: Speech and AI

Speech is a biomarker that reflects, in a sensitive way, the integrated functioning of several physiological systems, namely the nervous, respiratory, and muscular systems. This complexity makes it a promising resource for detecting changes associated…

Read more
Literatura sobre os cuidados de saúde no futuro

What Literature Reveals About Healthcare in the Future

The healthcare sector is undergoing rapid transformation driven by population aging, increasing complexity of care, and digital advancements, in a context that requires greater integration, sustainability and adaptation to new realities such as the European…

Read more
Perturbação do sono

A Digital Intervention for Insomnia in Oncology

Insomnia is a sleep disorder characterised by persistent difficulties in initiating sleep, maintaining sleep during the night, or achieving restful sleep. These difficulties arise even in the presence of adequate sleeping conditions and are often…

Read more
Sistema de telemonitorização remota

Digital Technology Revolutionising Post-cardiac Surgery

According to the World Health Organisation, cardiovascular disease remains the leading cause of death worldwide, responsible for around 17.9 million deaths a year. Its high prevalence is associated with unhealthy lifestyles characterised by poor diet,…

Read more
Sistema robótico autónomo INSIDE

Autonomous Robotics System for Autism Therapy

Autism spectrum disorder is a neurodevelopmental condition with significant clinical, social and economic repercussions throughout life. According to the World Health Organization, it is estimated to affect approximately 1 in 160 children worldwide. Its origin…

Read more
Enfermeira com um telefone

Mobile Application to Improve Workflows in Nursing Homes

Portugal has one of the highest aging populations in the world, placing increasing pressure on elderly care services, especially in nursing homes. Healthcare professionals in these facilities are often overwhelmed due to the increasing number…

Read more
troca de informações de saúde e interoperabilidade

New Era of Interoperability in Healthcare Systems

The growing use of electronic health records, digital diagnostic systems and remote monitoring technologies has led to a significant increase in the volume and complexity of health data. This increase intensifies the need for continuous,…

Read more
robótica colaborativa

Collaborative Robotics Improves Working Conditions

Workers face growing challenges in the industrial environment. Among the most critical are fatigue and inappropriate postures, often associated with repetitive tasks and working conditions that lack ergonomic suitability. These factors represent significant risks for…

Read more
Benefícios da Eletrônica Médica

Detection of Anxiety and Panic Attacks in Real Time

The growing number of people with anxiety disorders, along with increased awareness of mental health, drives the need for new technological tools that provide remote and continuous monitoring of anxiety and panic disorders. Thus, the…

Read more
tele-ecografia

A Novel Approach for Robotic-assisted Tele-echography

Currently, robotic systems for ultrasound diagnostic procedures fall into two main categories: portable robots that require manual positioning and fully autonomous robotic systems that independently control the ultrasound probe’s orientation and positioning. Portable robots rely…

Read more
Personalização e tecnologia na gestão da Diabetes

Personalization and Technology in Diabetes Management

IPDM has significant potential to improve diabetes management and drive health system reforms to become high-performing, effective, equitable, accessible, and sustainable. Evidence and good practices inspire health system transformation. Adopting person-centred approaches like co-creation and…

Read more
TEF-HEALTH Logo

SPMS Integrates the TEF-Health Initiative

SPMS participates in the TEF-Health initiative as a partner in a consortium composed of 51 entities from 9 European Union countries. This action is co-financed by the European Commission and has a duration of five…

Read more
Global Digital Health Partnership Logo

SPMS Represents Portugal as Vice-president of GDHP

The GDHP is an intergovernmental organization in the digital health sector that facilitates cooperation and collaboration between government representatives and the World Health Organization (WHO). Its purpose is to foster policymaking that promote the digitalization…

Read more
Portugal INCoDe.2030

Digital Transformation of Health at INCoDe.2030 in Tomar

The “National Digital Skills Initiative e.2030, Portugal” (INCoDe.2030) is an initiative that aims to improve the Portuguese population’s level of digital skills, placing Portugal at the level of the most advanced European countries in this…

Read more
HealthData@PT Logo

HealthData@PT: New SPMS Initiative for Health Data

Action HealthData@PT is launched in the context of the implementation of the European Health Data Space, and is an initiative approved by the European Commission under the EU4Health 2021-2027 programme. This initiative contributes to the…

Read more

Do you have an innovative idea in healthcare field?

Share it with us and see it come to life.
We will help bring your projects to life!

Newsletter

Receive the latest updates from the Inovarsaúde portal.

República Portuguesa logo
SNS Logo
SPMS Logo

Follow Us

YouTube
LinkedIn

Co-funded by

PRR Logotipo
República Portuguesa logo
União Europeia Logo
Scroll to Top